1. 00014 A PHASE II STUDY OF THE AGO OVARIAN CANCER STUDY GROUP (AGO-OVAR 2.6): ZD1839 IN COMBINATION WITH TAMOXIFEN IN REFRACTORY OVARIAN CANCER. (1st September 2005) Authors: Sehouli, J.; Wagner, U.; du Bois, A.; Pfisterer, J.; Houber, J.; Loibl, S.; Lueck, H. J.; Gropp, M.; Staehle, A.; Schmalfeldt, B.; Meier, W.; Jackisch, C. Journal: International journal of gynecological cancer Issue: Volume 15(2005)Supplement 2 Page Start: 55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 000197 THE ANTI-IDIOTYPIC MONOCLONAL ANTIBODY ACA125 IN PATIENTS WITH RECURRENT EPITHELIAL OVARIAN, FALLOPIAN TUBE OR PERITONEAL CANCER. A PHASE II TRIAL OF THE AGO-OVAR. (1st September 2005) Authors: Belau, A. K.; Kimmig, R.; Wollschlager, K.; Heilmann, V.; Harter, P.; Hilpert, F.; Sehouli, J.; Loibl, S.; Canzler, U.; Pfisterer, J. Journal: International journal of gynecological cancer Issue: Volume 15(2005)Supplement 2 Page Start: 106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 0074: Combination Therapy with Pegliposomal Doxoru-Bicin and Carboplatin in Gynecologic Tumours. a Phase-Ii Trial of the Ago-Ovar and the Ago Kommission Uterus. (1st October 2006) Authors: Harter, P.; Jackisch, C.; Belau, A.; Gropp, M.; Schmalfeldt, B.; Lueck, H. J.; Loibl, S.; Burchardi, N.; Pfisterer, J.; Du Bois, A. Journal: International journal of gynecological cancer Issue: Volume 16(2006)Supplement 3 Page Start: 621 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1801 Neoadjuvant chemotherapy with trastuzumab or lapatinib: Survival analysis of the HER2-positive cohort of the GeparQuinto study (GBG 44). (September 2015) Authors: Untch, M.; Von Minckwitz, G.; Gerber, B.; Eidtmann, H.; Rezai, M.; Fasching, P.A.; Tesch, H.; Eggemann, H.; Schrader, I.; Kittel, K.; Hanusch, C.; Huober, J.; Solbach, C.; Jackisch, C.; Kunz, G.; Blohmer, J.; Hauschild, M.; Fehm, T.; Nekljudova, V.; Loibl, S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S264 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 1815 A double blind phase 3 trial of fulvestrant with placebo or palbociclib in pre- and post-menopausal women with hormone receptor-positive (HR+ve), HER2-negative (HER2-ve) metastatic breast cancer (MBC) that progressed on prior endocrine therapy (PALOMA 3): Detailed analysis of patient-reported outcomes. (September 2015) Authors: Harbeck, N.; Cristofanilli, M.; Ro, J.; André, F.; Loi, S.; Verma, S.; Iwata, H.; Loibl, S.; Huang Bartlett, C.; Zhang, K.; Iyer, S.; Thiele, A.; Theall, K.; Koehler, M.; Turner, N. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S270 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 1830 Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques. (September 2015) Authors: Heil, J.; Kümmel, S.; Schaefgen, B.; Paepke, S.; Thomssen, C.; Rauch, G.; Ataseven, B.; Große, R.; Dreesmann, V.; Kühn, T.; Loibl, S.; Blohmer, J.U.; Minckwitz, G.V. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S275 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 1957 Ovarian suppression with luteinizing hormone-releasing hormone agonists during chemotherapy as a strategy to preserve ovarian function and fertility in breast cancer patients: A systematic review and meta-analysis of randomized studies. (September 2015) Authors: Lambertini, M.; Ceppi, M.; Poggio, F.; Peccatori, F.A.; Azim, H.A.; Ugolini, D.; Pronzato, P.; Loibl, S.; Moore, H.C.F.; Partridge, A.H.; Del Mastro, L. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S318 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 92OThe Breast International Group (BIG) AURORA pilot study for molecular screening in metastatic breast cancer (MBC) patients. (7th May 2015) Authors: Maetens, M.; Irrthum, A.; Loibl, S.; Laes, J.F.; Campbell, P.; Aftimos, P.; Thompson, A.; Cortes Castan, J.; Loi, S.; Sotiriou, C. Journal: Annals of oncology Issue: Volume 26(2015)Supplement 3 Page Start: iii31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A Phase III, Randomized, Multicenter, Double-blind Study to Compare Efficacy and Safety of EG12014 (EirGenix Trastuzumab) with Herceptin® as Neoadjuvant Treatment in Combination with Anthracycline/Paclitaxel-based Systemic Therapy in Patients with HER2-positive Early Breast Cancer. (November 2022) Authors: Henneberg, J.; Grohmann-Izay, B.; Huang, C.S.; Schulze, C.; Llinas, N.; Giorgi, D.; Misra, A.; Pominchuk, D.; Prokhorof, A.; Rapoport, B.; Semiglazov, V.; Tseng, L.M.; Yanez Ruiz, E.; Loibl, S. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. A survey on physicians' knowledge, practice and attitudes on fertility and pregnancy issues in young breast cancer patients. (March 2017) Authors: Lambertini, M.; Di Maio, M.; Pagani, O.; Demeestere, I.; Del Mastro, L.; Loibl, S.; Partridge, A.H.; Azim, H.H.; Peccatori, F.A. Journal: Breast Issue: Volume 32(2017)Supplement 1 Page Start: S85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗